MEDICAL DEVELOPMENTS ORDINARY (MVP) Short Interest
MEDICAL DEVELOPMENTS ORDINARY (ASX:MVP) had 0.02% of shares reported as short positions as of 26 June 2026, representing 22,489 shares. MEDICAL DEVELOPMENTS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
MVP
Medical Developments International
Pharmaceuticals, Biotechnology & Life Sciences
Medical Developments International (MVP) is a pharmaceutical company focused on developing and distributing innovative medical devices. They operate in the acute pain and respiratory illness treatment sectors, aiming to improve patient care globally. MDI partners with organizations like CSIRO to drive industry-leading product development.
pharmaceuticals
biotechnology
medical devices
pain management
Shorted
short percentage0.02%
reported shorts22.5K
shares on issue112.658M